Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
24.6 EUR | 0.00% |
|
+5.13% | +9.82% |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.24 for the current year.
- The stock, which is currently worth 2025 to 0.56 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company does not generate enough profits, which is an alarming weak point.
- The company is highly valued given the cash flows generated by its activity.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.82% | 1.73B | - | ||
+3.98% | 102B | A- | ||
-10.18% | 59.99B | A- | ||
+82.86% | 51.32B | B | ||
+8.46% | 34.84B | B | ||
+0.16% | 30.66B | A- | ||
+5.64% | 18.79B | B- | ||
+18.14% | 17.98B | C+ | ||
+9.26% | 13.79B | B- | ||
+78.32% | 13.28B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4118 Stock
- KKA Stock
- Ratings Kaneka Corporation